Owned by the Association for International Promotion & Study in Tumors (APSIT)
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
Cancer and its therapies increase the risk of venous thromboembolism. Compared to patients without cancer, patients with cancer anticoagulated for venous thromboembolism are more likely to develop recurrent th...
Citation: Journal of Experimental & Clinical Cancer Research 2008 27:21